Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,320 | 18,207 | 32,363 | 49,046 | 56,516 |
| TOTAL | $9,670 | $20,613 | $37,537 | $51,232 | $60,567 |
| Non-Current Assets | |||||
| PPE Net | 324 | 380 | 495 | 678 | 906 |
| Other Non-Current Assets | 5,914 | 6,136 | 258 | 512 | 763 |
| TOTAL | $6,238 | $6,516 | $753 | $1,190 | $1,669 |
| Total Assets | $15,908 | $27,129 | $38,290 | $52,422 | $62,236 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,811 | 15,795 | 15,452 | 13,704 | 18,211 |
| TOTAL | $17,984 | $16,600 | $16,006 | $14,540 | $19,462 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 29,161 | 27,274 | 21,737 | 23,617 | 19,806 |
| TOTAL | $29,161 | $27,274 | $21,737 | $23,617 | $19,806 |
| Total Liabilities | $47,145 | $43,874 | $37,743 | $38,157 | $39,268 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,792 | 58,722 | 58,418 | 58,401 | 48,346 |
| Common Shares | 6 | 6 | 6 | 6 | 5 |
| Retained earnings | -535,862 | -520,084 | -501,373 | -486,039 | -471,155 |
| TOTAL | $-31,237 | $-16,745 | $547 | $14,265 | $22,968 |
| Total Liabilities And Equity | $15,908 | $27,129 | $38,290 | $52,422 | $62,236 |